Interrogating DNA repair in cancer risk assessment

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 7, 2005, Pages 1585-1587

  Paz Elizur, Tamar ^a   Brenner, Dean E ^b,c   Livneh, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE DELTA; DNA DIRECTED DNA POLYMERASE EPSILON; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

CANCER RISK; DNA HELIX; DNA MODIFICATION; DNA REPAIR; DNA STRAND BREAKAGE; DNA SYNTHESIS; EDITORIAL; EXCISION REPAIR; GENE MUTATION; GENOTYPE ENVIRONMENT INTERACTION; HOMOLOGOUS RECOMBINATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA REPAIR; GENOTYPE; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 22244434171     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-7-ED     Document Type: Editorial

References (24)

1. Lindahl T, Wood R. Quality control by DNA repair. Science 1999;286: 1897-905.
2. Friedberg E, Walker G, Siede W. DNA repair and mutagenesis. Washington, DC: ASM Press; 1995.
3. Caporaso N. The molecular epidemiology of oxidative damage to DNA and cancer. J Natl Cancer Inst 2003;95:1263-5.
4. 6-alkylguaninine-DNA-alkyltransferase). Cancer Epidemiol Biomarkers Prev 2005;14:1774-83.
5. Wark P, Weijenberg M, van't Veer P, et al. Fruits, vegetables and hMLH1 protein deficient and proficient colon cancer: the Netherlands Cohort Study. Cancer Epidemiol Biomarkers Prev 2005;14:1619-25.
6. Kuschel B, Chenevix-Trench G, Spurdle A, et al. Common polymorphisms in ERCC2 (xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1828-31.
7. Ritchey J, Huang W, Chokkalingam A, et al. Genetic variants of DNA repair genes and prostate cancer: a population based study. Cancer Epidemiol Biomarkers Prev 2005;14:1703-9.
8. Lin J, Kadlubar F, Spitz MR, Zhao H, Wu X. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1832-6.
9. Huang W, Olshan A, Schwartz S, et al. Selected genetic polymorphisms in MGMT, XRCC1, XPD and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1747-53.
10. Berwick M, Vineis P. Measuring DNA repair capacity: small steps. J Natl Cancer Inst 2005;97:84-5.
11. Matullo G, Berwick M, Vineis P. Gene-environment interactions: how many false positives? J Natl Cancer Inst 2005;97:550-1.
12. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005;97:567-76.
13. Kennedy DO, Agrawal M, Shen J, et al. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005;97:127-32.
14. Lynch H, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78:1149-67.
15. Langland G, Elliott J, Li Y, Creaney J, Dixon K, Groden J. The BLM helicase is necessary for normal DNA double-strand break repair. Cancer Res 2002;62:2766-70.
16. Neff NF, Ellis NA, Ye TZ, et al. The DNA helicase activity of BLM is necessary for the correction of the genomic instability of Bloom syndrome cells. Mol Biol Cell 1999;10:665-76.
17. Bohr VA, Sander M, Kraemer KH. Rare diseases provide rare insights into DNA repair pathways, TFIIH, aging and cancer center. DNA Repair 2005;4: 293-302.
18. Marchetto MC, Muotri AR, Burns DK, Friedberg EC, Menck CF. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice. Proc Natl Acad Sci U S A 2004;101:17759-64.
19. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002;17:463-9.
20. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005;14:1810-8.
21. Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-72.
22. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003;95:1312-9.
23. Speina E, Zielinska M, Barbin A, et al. Decreased repair activities of 1,N(6)-ethenoadenine and 3,N(4)-ethenocytosine in lung adenocarcinoma patients. Cancer Res 2003;63:4351-7.
24. Gackowski D, Speina E, Zielinska M, et al. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 2003;63:4899-902.